Ko Willems van Dijk

25.7k total citations · 1 hit paper
268 papers, 9.3k citations indexed

About

Ko Willems van Dijk is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Ko Willems van Dijk has authored 268 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Molecular Biology, 88 papers in Physiology and 55 papers in Surgery. Recurrent topics in Ko Willems van Dijk's work include Adipose Tissue and Metabolism (57 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (41 papers) and Metabolomics and Mass Spectrometry Studies (39 papers). Ko Willems van Dijk is often cited by papers focused on Adipose Tissue and Metabolism (57 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (41 papers) and Metabolomics and Mass Spectrometry Studies (39 papers). Ko Willems van Dijk collaborates with scholars based in Netherlands, United States and United Kingdom. Ko Willems van Dijk's co-authors include Louis M. Havekes, Patrick C.N. Rensen, Marten H. Hofker, Peter J. Voshol, Sjoerd A.A. van den Berg, Vanessa van Harmelen, E C Milner, Jan B. van Klinken, Frits R. Rosendaal and Jimmy F.P. Berbée and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Ko Willems van Dijk

261 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit

2017 516 citations Sander Kooijman, Ko Willems van Dijk et al. profile →

Peers

Countries citing papers authored by Ko Willems van Dijk

Since Specialization

Citations

This map shows the geographic impact of Ko Willems van Dijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ko Willems van Dijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ko Willems van Dijk more than expected).

Fields of papers citing papers by Ko Willems van Dijk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ko Willems van Dijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ko Willems van Dijk. The network helps show where Ko Willems van Dijk may publish in the future.

Co-authorship network of co-authors of Ko Willems van Dijk

This figure shows the co-authorship network connecting the top 25 collaborators of Ko Willems van Dijk. A scholar is included among the top collaborators of Ko Willems van Dijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ko Willems van Dijk. Ko Willems van Dijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term body mass index trajectories and the risk of type 2 diabetes mellitus and atherosclerotic cardiovascular disease using healthcare data from UK Biobank participants 2025 ·Atherosclerosis ·Anja Krüger, Ko Willems van Dijk, (unknown), Raymond Noordam	1
2	Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites 2025 ·The Journals of Gerontology Series A ·Tariq Faquih, Astrid van Hylckama Vlieg, Praveen Surendran, Adam S. Butterworth, Ruifang Li‐Gao, Renée de Mutsert, Frits R. Rosendaal, Raymond Noordam, Diana van Heemst, Ko Willems van Dijk, (unknown)	1
3	No evidence linking sleep traits with white blood cell counts: Multivariable‐adjusted and Mendelian randomization analyses 2024 ·European Journal of Clinical Investigation ·Raymond Noordam, (unknown), (unknown), Ko Willems van Dijk, Diana van Heemst	1
4	Cardiovascular risk factors and major recurrent coronary events: A genetic liability study in patients with coronary artery disease in the UK Biobank 2023 ·Atherosclerosis ·Raymond Noordam, (unknown), Yvonne M. Drewes, Jacobijn Gussekloo, Simon P. Mooijaart, Ko Willems van Dijk, Stella Trompet, J. Wouter Jukema, Diana van Heemst	1
5	The impact of sociodemographic status on the association of classical cardiovascular risk factors with coronary artery disease: a stratified Mendelian randomization study 2023 ·Journal of Clinical Epidemiology ·(unknown), (unknown), Saskia le Cessie, Ko Willems van Dijk, Diana van Heemst, Raymond Noordam	4
6	Differential and sex‐ and age‐specific risks of cardiometabolic diseases with unrelated metabolic syndrome dimensions 2023 ·Obesity ·(unknown), Ko Willems van Dijk, Diana van Heemst, Raymond Noordam	1
7	The association between mitochondrial DNA abundance and stroke: A combination of multivariable-adjusted survival and Mendelian randomization analyses 2022 ·Atherosclerosis ·(unknown), Jiao Luo, Marieke J.H. Wermer, Ko Willems van Dijk, Sara Hägg, Felix Graßmann, Raymond Noordam, Diana van Heemst	9
8	Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses 2022 ·Journal of Lipid Research ·Dorina Ibi, (unknown), Martijn E.T. Dollé, J. Wouter Jukema, Frits R. Rosendaal, Constantinos Christodoulides, Matt J. Neville, Robert W. Koivula, Patrick C.N. Rensen, Fredrik Karpe, Raymond Noordam, Ko Willems van Dijk	5
9	Low leukocyte mitochondrial DNA abundance drives atherosclerotic cardiovascular diseases: a cohort and Mendelian randomization study 2022 ·Cardiovascular Research ·Jiao Luo, Raymond Noordam, J. Wouter Jukema, Ko Willems van Dijk, Sara Hägg, Felix Graßmann, Saskia le Cessie, Diana van Heemst	9
10	Clustered Mendelian randomization analyses identify distinct and opposing pathways in the association between genetically influenced insulin-like growth factor-1 and type 2 diabetes mellitus 2022 ·International Journal of Epidemiology ·(unknown), (unknown), Jan B. van Klinken, Ko Willems van Dijk, Andrzej Bartke, Diana van Heemst, Raymond Noordam	10
11	The APOE locus is linked to decline in general cognitive function: 20-years follow-up in the Doetinchem Cohort Study 2022 ·Translational Psychiatry ·(unknown), N. Charlotte Onland‐Moret, Astrid C. J. Nooyens, Dorina Ibi, Ko Willems van Dijk, (unknown), Jeroen L. A. Pennings, Maarten Schipper, Albert Wong, Annemieke M. W. Spijkerman, Martijn E.T. Dollé, W. M. Monique Verschuren	2
12	Differential insulin sensitivity of NMR-based metabolomic measures in a two-step hyperinsulinemic euglycemic clamp study 2021 ·Metabolomics ·Wenyi Wang, Ko Willems van Dijk, Carolien A. Wijsman, Maarten Pieter Rozing, Simon P. Mooijaart, Marian Beekman, P. Eline Slagboom, J. Wouter Jukema, Raymond Noordam, Diana van Heemst	0
13	Classical risk factors for primary coronary artery disease from an aging perspective through Mendelian Randomization 2021 ·GeroScience ·(unknown), (unknown), Stella Trompet, (unknown), Simon P. Mooijaart, Ko Willems van Dijk, Diana van Heemst, Raymond Noordam	11
14	Apolipoprotein E genotype, lifestyle and coronary artery disease: Gene-environment interaction analyses in the UK Biobank population 2021 ·Atherosclerosis ·Maxime M. Bos, (unknown), Patrick C.N. Rensen, Ko Willems van Dijk, Gerard J. Blauw, Diana van Heemst, Raymond Noordam	8
15	Stratification of Type 2 Diabetes by Age of Diagnosis in the UK Biobank Reveals Subgroup-Specific Genetic Associations and Causal Risk Profiles 2021 ·Diabetes ·Raymond Noordam, Kristi Läll, Roelof A. J. Smit, Triin Laisk, Andres Metspalu, Tōnu Esko, Lili Milani, Ruth J. F. Loos, Reedik Mägi, Ko Willems van Dijk, Diana van Heemst	20
16	Lifestyle Risk Score: handling missingness of individual lifestyle components in meta-analysis of gene-by-lifestyle interactions 2021 ·European Journal of Human Genetics ·Hanfei Xu, Karen Schwander, Michael R. Brown, Wenyi Wang, (unknown), Eric Boerwinkle, L. Adrienne Cupples, Lisa de las Fuentes, Diana van Heemst, Oyomoare L. Osazuwa‐Peters, Paul S. de Vries, Ko Willems van Dijk, Yan V. Sun, Xiaoyu Zhang, Alanna C. Morrison, D. C. Rao, Raymond Noordam, Ching‐Ti Liu	3
17	Fasting in diabetes treatment (FIT) trial: study protocol for a randomised, controlled, assessor-blinded intervention trial on the effects of intermittent use of a fasting-mimicking diet in patients with type 2 diabetes 2020 ·BMC Endocrine Disorders ·(unknown), (unknown), Petra G. van Peet, M. Elske van den Akker‐van Marle, Ko Willems van Dijk, Valter D. Longo, Hildo J. Lamb, Mattijs E. Numans, Hanno Pijl	14
18	Genome-wide Association Study of the Postprandial Triglyceride Response Yields Common Genetic Variation in Hepatic Lipase (LIPC) 2020 ·Circulation Genomic and Precision Medicine ·Dorina Ibi, Raymond Noordam, Jan B. van Klinken, Ruifang Li‐Gao, Renée de Mutsert, Stella Trompet, Tim Christen, Lisanne L. Blauw, Diana van Heemst, Dennis O. Mook‐Kanamori, Frits R. Rosendaal, J. Wouter Jukema, Martijn E.T. Dollé, Patrick C.N. Rensen, Ko Willems van Dijk	3
19	Associations of Outdoor Temperature, Bright Sunlight, and Cardiometabolic Traits in Two European Population-Based Cohorts 2019 ·The Journal of Clinical Endocrinology & Metabolism ·Raymond Noordam, Ashna Ramkisoensing, Nellie Y. Loh, Matt J. Neville, Frits R. Rosendaal, Ko Willems van Dijk, Diana van Heemst, Fredrik Karpe, Constantinos Christodoulides, Sander Kooijman	15
20	Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor 1999 ·Biochemical Journal ·(unknown), Ko Willems van Dijk, (unknown), (unknown), (unknown), (unknown), Gérard Siest, Lawrence Chan, Marten H. Hofker, Louis M. Havekes	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact